Problems of Patent Financed Drug Research #43,783, Ignoring Non-Patentable Treatments

April 23, 2014

In principle we might think that researchers should be examining the most promising options for treating disease. But the patent system only provides incentives to pursue treatments that are expected to lead to a patentable drug. Therefore we may see many potentially effective treatments ignored, as appears to be the case with the cancer treatment featured in this Pro Publica piece.

Comments

Support Cepr

APOYAR A CEPR

If you value CEPR's work, support us by making a financial contribution.

Si valora el trabajo de CEPR, apóyenos haciendo una contribución financiera.

Donate Apóyanos

Keep up with our latest news